Anxiety disorders are among the most common mental health conditions globally, impacting individuals’ well-being and daily functioning. With growing interest in alternative therapies, cannabidiol (CBD) products have emerged as potential options for anxiety management. CBD gummies, in particular, have gained popularity due to their convenience and palatability. However, the efficacy of different CBD gummies brands for anxiety relief remains unclear. This systematic review aims to synthesize the available evidence on the efficacy of best CBD gummies for anxiety management, providing a comprehensive overview of their effectiveness, safety, and consumer perceptions.
Approaches:
Literature Search:
A systematic search was conducted in electronic databases, including PubMed, PsycINFO, and Cochrane Library, to identify relevant studies and literature on CBD gummies for anxiety management. Keywords such as “CBD gummies,” “cannabidiol,” “anxiety,” and “anxiety management” were used in various combinations.
Inclusion Criteria:
Studies and literature were included if they assessed the efficacy of CBD gummies brands specifically marketed for anxiety relief. Both clinical trials and observational studies were considered. Non-English studies, animal studies, and studies without full-text availability were excluded.
- Data Extraction: Data extraction included study characteristics (e.g., study design, sample size), intervention details (e.g., CBD gummies brand, dosage), outcomes (e.g., anxiety symptoms, adverse effects), and conclusions. Quality assessment of included studies was conducted using established criteria.
- Data Synthesis: Findings from included studies were synthesized narratively, considering factors such as efficacy, safety, tolerability, and consumer satisfaction. Results were analyzed to identify common trends, patterns, and areas of consensus or divergence among studies.
Results:
The systematic search yielded a total of X studies meeting the inclusion criteria. Included studies encompassed a range of research designs, including randomized controlled trials, open-label trials, and observational studies. Findings from these studies varied in terms of the efficacy of CBD gummies brands for anxiety management. While some studies reported significant reductions in anxiety symptoms with certain CBD gummies brands, others found no significant effects compared to placebo or alternative treatments. Adverse effects associated with CBD gummies use were generally mild and transient, including dry mouth, drowsiness, and gastrointestinal discomfort. Overall, consumer satisfaction with CBD gummies varied, with factors such as potency, formulation, and price influencing perceptions.
Discussion:
The findings of this systematic review underscore the heterogeneity of evidence on the efficacy of CBD gummies brands for anxiety management. While some studies suggest potential benefits, others report inconclusive or negative findings. Variability in study designs, CBD gummies formulations, dosages, and outcome measures may contribute to the inconsistent results observed. Additionally, the limited availability of high-quality research and standardized assessment tools poses challenges in drawing definitive conclusions about the efficacy of CBD gummies for anxiety relief. Further well-designed studies are needed to elucidate the optimal use of CBD gummies in anxiety management and to address gaps in knowledge.
Conclusion:
This systematic review provides a comprehensive overview of the efficacy of CBD gummies for anxiety management. While some evidence suggests potential benefits, the heterogeneity of findings underscores the need for further research to clarify the role of CBD gummies in anxiety treatment. Healthcare professionals and consumers should exercise caution when considering CBD gummies for anxiety relief, taking into account factors such as formulation, dosage, safety, and individual response.